Pedro Moreno, PhD

I3S - Instituto para a Investigação e Inovação em Saúde, Universidade do Porto nanoBiomaterials for Targeted Therapies Group

Pedro Moreno is a senior researcher at the Institute for Research and Innovation in Health (i3S) at the nanoBiomaterials for Targeted Therapies group.

Pedro has a Biochemistry degree from the University of Coimbra and a PhD in Cell and Molecular Biology from the Karolinska Institute, where he initiated his research work in genetic therapies and gene delivery.

In 2013 he was awarded a Marie Curie European fellowship from the European Commission to proceed his studies at the Institute of Biomedical Engineering (INEB) in Porto.

Currently at i3S he focus his research on development of novel RNA therapeutics and nanodelivery vectors for neuro-regeneration and cancer therapy. Pedro has published more than 30 research papers in his subject, several book chapters and is named inventor in two awarded international patents and one provisional patent application. Additionally, he also collaborates with industry as a consultant and advisor in the field of RNA therapeutics.

In 2021 he was the promoter and successfully set-up the first international symposium on oligonucleotide therapeutics in Portugal (OTP2021).